These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 3731113)

  • 1. Secretion of an insulin-like growth factor-I-related protein by human breast cancer cells.
    Huff KK; Kaufman D; Gabbay KH; Spencer EM; Lippman ME; Dickson RB
    Cancer Res; 1986 Sep; 46(9):4613-9. PubMed ID: 3731113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization and hormonal regulation of radioimmunoassayable IGF-I (insulin-like growth factor I) like activity and IGF-binding proteins secreted by human breast cancer cells.
    Ahmed SR; Manni A; Gray G; Hammond JM
    Anticancer Res; 1990; 10(5A):1217-23. PubMed ID: 1700662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of insulin-like growth factor-binding-protein-1, 2, 3, 4, 5, and 6: synthesis, secretion, and gene expression in estrogen receptor-negative human breast carcinoma cells.
    Sheikh MS; Shao ZM; Hussain A; Clemmons DR; Chen JC; Roberts CT; LeRoith D; Fontana JA
    J Cell Physiol; 1993 Jun; 155(3):556-67. PubMed ID: 7684042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth inhibition of human breast cancer cells in vitro with an antibody against the type I somatomedin receptor.
    Arteaga CL; Osborne CK
    Cancer Res; 1989 Nov; 49(22):6237-41. PubMed ID: 2553250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of estrogen-induced insulin-like growth factors in the proliferation of human breast cancer cells.
    van der Burg B; Isbrücker L; van Selm-Miltenburg AJ; de Laat SW; van Zoelen EJ
    Cancer Res; 1990 Dec; 50(24):7770-4. PubMed ID: 2174732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant insulin-like growth factor binding protein-1 inhibits IGF-I, serum, and estrogen-dependent growth of MCF-7 human breast cancer cells.
    Figueroa JA; Sharma J; Jackson JG; McDermott MJ; Hilsenbeck SG; Yee D
    J Cell Physiol; 1993 Nov; 157(2):229-36. PubMed ID: 7693722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential responsiveness of human breast cancer cell lines MCF-7 and T47D to growth factors and 17 beta-estradiol.
    Karey KP; Sirbasku DA
    Cancer Res; 1988 Jul; 48(14):4083-92. PubMed ID: 3289739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth factors and chemotherapeutic modulation of breast cancer cells.
    Ciftci K; Su J; Trovitch PB
    J Pharm Pharmacol; 2003 Aug; 55(8):1135-41. PubMed ID: 12956904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autocrine production of insulin-like growth factor II using an inducible expression system results in reduced estrogen sensitivity of MCF-7 human breast cancer cells.
    Daly RJ; Harris WH; Wang DY; Darbre PD
    Cell Growth Differ; 1991 Sep; 2(9):457-64. PubMed ID: 1661135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin-like growth factor binding protein (IGFBP)-3 levels in conditioned media of Hs578T human breast cancer cells are post-transcriptionally regulated.
    Oh Y; Müller HL; Pham H; Lamson G; Rosenfeld RG
    Growth Regul; 1993 Mar; 3(1):84-7. PubMed ID: 7683543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-like growth factors modulate the growth inhibitory effects of retinoic acid on MCF-7 breast cancer cells.
    Bentel JM; Lebwohl DE; Cullen KJ; Rubin MS; Rosen N; Mendelsohn J; Miller WH
    J Cell Physiol; 1995 Oct; 165(1):212-21. PubMed ID: 7559803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin-like growth factor II mRNA expression in human breast cancer.
    Yee D; Cullen KJ; Paik S; Perdue JF; Hampton B; Schwartz A; Lippman ME; Rosen N
    Cancer Res; 1988 Dec; 48(23):6691-6. PubMed ID: 3180080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for autocrine mitogenic stimulation by somatomedin-C/insulin-like growth factor I on an established human lung cancer cell line.
    Minuto F; Del Monte P; Barreca A; Alama A; Cariola G; Giordano G
    Cancer Res; 1988 Jul; 48(13):3716-9. PubMed ID: 3378214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin-like growth factor-binding protein enhancement of insulin-like growth factor-I (IGF-I)-mediated DNA synthesis and IGF-I binding in a human breast carcinoma cell line.
    Chen JC; Shao ZM; Sheikh MS; Hussain A; LeRoith D; Roberts CT; Fontana JA
    J Cell Physiol; 1994 Jan; 158(1):69-78. PubMed ID: 7505280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin receptor expression and function in human breast cancer cell lines.
    Milazzo G; Giorgino F; Damante G; Sung C; Stampfer MR; Vigneri R; Goldfine ID; Belfiore A
    Cancer Res; 1992 Jul; 52(14):3924-30. PubMed ID: 1617668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multihormonal regulation of insulin-like growth factor-I-related protein in MCF-7 human breast cancer cells.
    Huff KK; Knabbe C; Lindsey R; Kaufman D; Bronzert D; Lippman ME; Dickson RB
    Mol Endocrinol; 1988 Mar; 2(3):200-8. PubMed ID: 3041262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production of insulin-like growth factor-II (MSA) by endoderm-like cells derived from embryonal carcinoma cells: possible mediator of embryonic cell growth.
    Nagarajan L; Anderson WB; Nissley SP; Rechler MM; Jetten AM
    J Cell Physiol; 1985 Aug; 124(2):199-206. PubMed ID: 4044654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IGF-I differentially regulates IGF-binding protein expression in primary mammary fibroblasts and epithelial cells.
    Fleming JM; Leibowitz BJ; Kerr DE; Cohick WS
    J Endocrinol; 2005 Jul; 186(1):165-78. PubMed ID: 16002546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpressed IGF-I receptors reduce estrogen growth requirements, enhance survival, and promote E-cadherin-mediated cell-cell adhesion in human breast cancer cells.
    Guvakova MA; Surmacz E
    Exp Cell Res; 1997 Feb; 231(1):149-62. PubMed ID: 9056422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of estrogen responsive transforming activity in human breast cancer cell lines.
    Dickson RB; Bates SE; McManaway ME; Lippman ME
    Cancer Res; 1986 Apr; 46(4 Pt 1):1707-13. PubMed ID: 2418952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.